Prothrombin Complex Concentrates Market (PPC), By Type (3-Factor PCC and 4-Factor PCC), By Application (Acquired Coagulation Factor Deficiency, Congenital Coagulation Factor Deficiency, and Others), By End-User (Hospital, Ambulatory Surgical Centres and Others), Forecast (2022-2028)

The global prothrombin complex concentrates market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Prothrombin concentrates also known as prothrombin complex concentrates (PCC) are drugs that contain various concentrations and the PCCs are used to treat patients with hemophilia B and are used for those who do not have these adequate features for other reasons such as warfarin treatment. Significant increase in prescription anticoagulants, especially warfarin, as well as increased levels of blood disorders, are expected to boost the market.

In addition, major prothrombin complex concentrates manufacturers have reported changes in purchasing patterns of products derived from plasma, favoring market growth. Therefore, drug giants such as Grifols and CSL are seeing a gradual increase in revenue, due to increased production from plasma centers and Kcentra growth by two digits, and this is expected to have a positive impact on the overall market growth. For instance,in 2019 January  Grifols S.A. has acquired a US branch of Biotest pharmaceuticals corporation to improve its presence in North America and as a result of this discovery, Grifols will likely gain access to Biotest plasma collection centers, in order to increase the supply of plasma proteins that will be used for therapeutic purposes.

According to the National Action Plan for Drug Event Presentation, more than 30 million doctors have prescribed warfarin each year. However, this drug is associated with adverse drug reactions, requiring urgent reversal where prothrombin complex concentrate is the preferred treatment due to its rapid action and low risk of viral transmission. Therefore, an increase in warfarin prescribing is estimated to improve prothrombin complex concentrates market growth. For instance,in 2019 march, Grifols S.A. entered into a strategic agreement to control the 26.2% allocation of Shanghai RAAS to secure a minimum allocation to Grifols Diagnostic Solutions. The alliance will help Grifols grow its plasma-based products in the Chinese market.

The market for prothrombin complex concentrates is largely controlled by global manufacturers and manufacturers of prothrombin complex concentrate compete based on the adoption of prothrombin complex concentrates. In addition, the growing demand for improved and sustainable health care has created significant growth opportunities for global manufacturers. For instance, in 2019, the US Food and Drug Administration (FDA) approved an Octapharma USA’s Biological License (BLA) License for octuplex 4-Factor PCC, for indication of reversal of anticoagulation therapy in patients treated vitamin K antagonist therapy with the need for urgent surgery.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
  • By End-Users
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-Merck & Co., Inc., GlaxoSmithKline plc, Sanofi SA, Kedrion Biopharma Inc.,and Pfizer Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Prothrombin Complex Concentrates Market Report by Segment

By Type

• 3-FactorPCC
• 4-Factor PCC

By Application

• Acquired Coagulation Factor Deficiency
• Congenital Coagulation Factor Deficiency
• Others

By End-Users

• Hospital
• Ambulatory Surgical Centres
• Others

Prothrombin complex concentrates Market Report by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa